Answer
One-Alpha (alfacalcidol) injection treats calcium-metabolism disturbances due to impaired 1α-hydroxylation, including renal osteodystrophy, hyperparathyroidism with bone disease, hypoparathyroidism, neonatal hypocalcaemia, and nutritional, malabsorptive, pseudo-deficiency (D-dependent), or hypophosphataemic vitamin D-resistant rickets and osteomalacia.
Sources for this answer
- One-Alpha InjectionNeon Healthcare Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 14Document updated
Sources checked